Platypus Bio: Medical diagnosis software for the early identification of illnesses

Link to Github: link

Link to slides: link

Link to white paper: link

Overview A 90 percent delivery rate of primary preventive services could reduce expenditures by $53.9 billion (3.1 percent of 2006 personal healthcare expenditures [PHCE]) at a cost of $52.1 billion for a net cost reduction of 1.8 billion (.1 percent of 2006 PHCE). Achieving the same delivery rate of secondary services would cost an estimated $5.3 billion with an associated savings of $.2 billion for a net cost increase of $5.1 billion (.3 percent of 2006 PHCE). (Institute of Medicine (US) Roundtable on Evidence-Based Medicine; Yong PL, Saunders RS, Olsen LA, editors. The Healthcare Imperative: Lowering Costs and Improving Outcomes: Workshop Series Summary. Washington (DC): National Academies Press (US); 2010. 6, Missed Prevention Opportunities. Available from: We aim to scale our assistive technology for the early detection of illnesses to reach hospital systems in the U.S. west (California, Arizona, New Mexico), the U.S. midwest (Illinois, Indiana, Kentucky, Tennessee, Mississippi) and the U.S. north-west (Montana, North Dakota and Wyoming).

Background “An ounce of prevention is worth a pound of cure.” This saying is reflected in proposed health reform plans and the efforts to increase investments in prevention throughout the U.S. healthcare delivery system. With evidence that nearly 40 percent of all deaths in the United States are due to behavioral causes, attention to prevention has encompassed obesity and tobacco smoking prevention in addition to vaccinations and cancer screening (Mokdad et al., 2004) An aging population, many with multiple chronic conditions (Martini et al., 2007; Meara et al., 2004), has resulted in targeted prevention of additional complications and hospitalizations. (NIH) In considering strategies to control the rising costs of healthcare, the projected increase in the prevalence of chronic diseases is both cause for concern and an opportunity for intervention. The aging population and advances in medical care that enhance life expectancy are increasing the prevalence of chronic diseases, exerting upward pressure on healthcare spending. Past increases in the prevalence of chronic disease accounted for an estimated $211 billion of the $314 billion increase in healthcare spending in the United States between 1987 and 2000 (Thorpe, 2005). Between 2005 and 2030, the number of individuals with chronic disease is predicted to increase from 133 million to 171 million (Horvath, 2002), with profound implications for public health and the economy. (NIH)

Goals Making confidentiality a priority: Our collection and storage of data of patient information is HIPAA compliant and decentralized using blockchain technology to prevent theft of confidential information. Procedure: Hospitals send us data safely. Results are then connected to the patient’s ssn after a previously specified amount of time. Confidential and compliant post-diagnosis counseling. Reducing the number of patient-person interactions: Communication primarily through our website. Communication of services to at-risk individuals in rural settings: Our machine learning model based on patients’ past data, can provide 1) bubble plots of patient condition overview; 2) ranking of high potential risky diseases; and 3) symptom analysis for doctors as a support to better make the treatment decision and take potential risks into the consideration. Discreet product: Contributing towards anonymity; the target customer should be able to keep their testing usage private. Post-diagnosis support services: If the diagnosis is positive for certain diseases, then the customer will receive a step by step guide for seeking therapy.

Competitors' Company Main Weaknesses 23andme Company mission and marketing targets individual buyers Primarily a mailing service

Available Resources

Built With

Share this project: